Skip to content

Apotheek Stabroek: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Stabroek

BE 0633.677.145
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€32,145
2024 · €78,001-€45,856
Equity
-€65,851
2024 · -€97,996+€32,145
Cash
€73,916
2024 · €57,172+€16,744
Balance sheet total
€662,858
2024 · €573,684+€89,174

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€56,917

    up €56,917 (+48.7%), from €116,981 to €173,898

    of which Trade receivables: +€52,497

  • Tangible fixed assets +€34,102

    up €34,102 (+19.9%), from €171,598 to €205,700

    of which Leasing and similar rights: +€62,415

  • Cash +€16,744

    up €16,744 (+29.3%), from €57,172 to €73,916

    mainly Debts after one year (+€114,860) and Trade debts (+€62,028)

  • Stocks and contracts -€10,450

    down €10,450 (-5.6%), from €187,047 to €176,597

Equity and liabilities
  • Other debts -€149,823

    down €149,823 (-91.6%), from €163,534 to €13,711

  • Debts after one year +€114,860

    up €114,860 (+35.6%), from €322,389 to €437,249

  • Trade debts +€62,028

    up €62,028 (+61.9%), from €100,261 to €162,290

  • Current portion of long-term debt +€32,272

    up €32,272 (+96.5%), from €33,454 to €65,725

  • Profit (loss) carried forward +€32,145

    up €32,145 (+29.2%), from -€110,196 to -€78,051

Income statement
  • Staff costs +€45,103

    up €45,103 (+18.8%), from €239,940 to €285,043

  • Financial charges +€3,942

    up €3,942 (+26.7%), from €14,750 to €18,692

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €78,001
Gross operating margin +€996
Staff costs -€45,103
Depreciation +€2,677
Other operating charges -€2
Financial income -€483
Financial charges -€3,942
Result 2025 €32,145
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€49,613
Investment -€80,775
Financing +€147,131
Cash 2024 €57,172
Net result for the year +€32,145
Depreciation +€52,657
Stocks and contracts +€10,450
Receivables within one year -€56,917
Deferred charges and accrued income +€2,155
Trade debts +€62,028
Tax, wage and social debts -€3,905
Advances received -€588
Other debts -€149,823
Accrued charges and deferred income +€2,185
Investment in fixed assets (net) -€80,775
Debts after one year +€114,860
Current portion of long-term debt +€32,272
Cash 2025 €73,916
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €573,684 €662,858 +€89,174 +15.5%
Fixed assets 21/28 €188,162 €216,280 +€28,118 +14.9%
Intangible fixed assets 21 €15,984 €10,000 -€5,984 -37.4%
Tangible fixed assets 22/27 €171,598 €205,700 +€34,102 +19.9%
Plant, machinery and equipment 23 €1,703 €69 -€1,634 -96.0%
Furniture and vehicles 24 €10,907 €8,225 -€2,682 -24.6%
Leasing and similar rights 25 - €62,415 +€62,415
Other tangible fixed assets 26 €158,988 €134,991 -€23,997 -15.1%
Financial fixed assets 28 €580 €580 = 0.0%
Current assets 29/58 €385,523 €446,578 +€61,056 +15.8%
Stocks and contracts in progress 3 €187,047 €176,597 -€10,450 -5.6%
Stocks 30/36 €187,047 €176,597 -€10,450 -5.6%
Amounts receivable within one year 40/41 €116,981 €173,898 +€56,917 +48.7%
Trade receivables 40 €109,934 €162,430 +€52,497 +47.8%
Other amounts receivable 41 €7,048 €11,468 +€4,420 +62.7%
Cash at bank and in hand 54/58 €57,172 €73,916 +€16,744 +29.3%
Deferred charges and accrued income 490/1 €24,322 €22,167 -€2,155 -8.9%
Total equity and liabilities 10/49 €573,684 €662,858 +€89,174 +15.5%
Equity 10/15 -€97,996 -€65,851 +€32,145 +32.8%
Contributions 10/11 €12,200 €12,200 = 0.0%
Profit (loss) carried forward 14 -€110,196 -€78,051 +€32,145 +29.2%
Amounts payable 17/49 €671,680 €728,709 +€57,029 +8.5%
Amounts payable after more than one year 17 €322,389 €437,249 +€114,860 +35.6%
Financial debts 170/4 €322,389 €437,249 +€114,860 +35.6%
Amounts payable within one year 42/48 €330,827 €270,811 -€60,016 -18.1%
Current portion of amounts payable after more than one year 42 €33,454 €65,725 +€32,272 +96.5%
Trade debts 44 €100,261 €162,290 +€62,028 +61.9%
Suppliers 440/4 €100,261 €162,290 +€62,028 +61.9%
Advances received on contracts in progress 46 €2,583 €1,995 -€588 -22.8%
Taxes, remuneration and social security 45 €30,995 €27,090 -€3,905 -12.6%
Taxes 450/3 €1,576 €0 -€1,576 -100%
Remuneration and social security 454/9 €29,419 €27,090 -€2,329 -7.9%
Other amounts payable 47/48 €163,534 €13,711 -€149,823 -91.6%
Accrued charges and deferred income 492/3 €18,464 €20,649 +€2,185 +11.8%
Remuneration, social security and pensions 62 €239,940 €285,043 +€45,103 +18.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €55,334 €52,657 -€2,677 -4.8%
Other operating charges 640/8 €118 €120 +€2 +1.7%
Gross operating margin 9900 €384,878 €385,874 +€996 +0.3%
Operating profit (loss) 9901 €89,486 €48,055 -€41,431 -46.3%
Financial income 75/76B €3,264 €2,782 -€483 -14.8%
Recurring financial income 75 €3,264 €2,782 -€483 -14.8%
Financial charges 65/66B €14,750 €18,692 +€3,942 +26.7%
Recurring financial charges 65 €14,750 €18,692 +€3,942 +26.7%
Profit (loss) for the period before taxes 9903 €78,001 €32,145 -€45,856 -58.8%
Profit (loss) for the period 9904 €78,001 €32,145 -€45,856 -58.8%
Profit (loss) for the period to be appropriated 9905 €78,001 €32,145 -€45,856 -58.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.